What are the specific elements about the Austrian market access pathway, Dr. Anna Bucsics?
The Austrian market access pathway in the outpatient setting is unique in its pragmatic approach with their box system. The [...]
EU Joint Clinical Assessment for Drugs and Medical Devices on the Horizon
The EU has begun its transition to pan-European joint clinical assessment. The move will replace the current system of [...]
Bringing Patient Voices into Health Technology Assessment
In a new Frontiers in Medical Technology perspective, authors Janet L. Wale and colleagues make the case that patient input [...]
Balancing Market Access and Regulatory Requirements
Bringing a clinical product or service to market requires a careful strategy that ensures regulatory approval and value for payers. [...]
4 Trends to Watch for Medical Device Quality Professionals
The COVID-19 pandemic accelerated the digital transformation of the medical device industry and changed the game for the field’s quality [...]
Webinar: What Clinicians Need to Know About the Health Economic Profile of New Pharmaceuticals
Health technology assessments (HTAs) and health economic evaluations have become a pivotal fixture in market access decisions for therapeutics and [...]
Call for Abstracts: R for Health Technology Assessment Workshop
Abstract submissions are open for the R for Health Technology Assessment (HTA) workshop hosted by St. Anne’s College, University of [...]
RWE in Pharma Interview Series: Clare Hague
Clare Hague, EMEA Therapeutic Area Market Access Leader at Janssen, was featured in The Evidence Base’s RWE in Pharma series [...]
Vaccines and Value Assessment – 7 Updates
Navigating the evaluation requirements from health technology assessment (HTA) agencies and national immunization technical agency groups (NITAGs) is a must [...]
NICE’s 5-Year Strategy Signals a More Collaborative Approach.
The UK’s National Institute for Health and Care Excellence (NICE) new health technology assessment manual signals a push towards greater [...]
What the European Union can Teach the US About Health Technology Assessment Harmonization
Health Technology Assessment (HTA) in the US is a convoluted piecemeal process where each payer performs their own assessments without [...]
Webinar: Cost-effectiveness of R vs. Excel in Health Technology Assessments
On Wednesday, December 15th at 12:OOPM EST, Jeroen Jansen, Petros Pechlivanoglou, and Howard Thom will present a webinar examining the [...]
Changing Dynamics Between NICE and Pharmaceutical Industry
Recent shifts in the UK’s National Institute for Health and Care Excellence’s (NICE) approach to health technology assessment (HTA) are [...]
HTA Submissions and Single-Arm Trials: An ISPOR EUROPE Panel Presentation
On December 2nd (11 AM to 12 PM), the use of single-arm trials for Health Technology Appraisal (HTA) will be [...]
ISPOR Hosts Virtual Middle East and Africa 2021 HTA Roundtable
The International Society for Pharmacoeconomics and Outcomes (ISPOR) hosts regular meetings to discuss the adoption of health technology assessments (HTAs). These [...]
Comprehensive Literature Review on HTA Applications of Regulatory Sandboxes Now Available
A recent article, published in Applied Health Economics and Health Policy, describes how the regulatory sandbox could impact Health Technology [...]
Veradigm Announces Collaboration With CareMetx to Streamline Patient Access to Specialty Medications
Veradigm has announced a new partnership with CarMetx. The collaboration will streamline patient access to specialty medications using Veradigm’s automated [...]
Quantitative Scientist Discusses Considerations for HTAs Using RWD
Dr. Philani Brian Mpofu discusses important considerations for health technology assessments (HTAs) using real world data (RWD) to understand drug [...]
How Can NMAs and ITCs Add Value to HTAs?
The Evidence Base recently interviewed Dutch researcher Daan Reid. He shared his thoughts on health technology assessments (HTAs) and improving [...]
HTAs Fail to Address Healthcare Disparities in Value Assessments
Health and healthcare disparities continue to impact care and outcomes in diverse patient populations. Health technology assessments (HTAs) fail to [...]
Apply Today for EMAUD’s International Market Access Program
Interested medical affairs (MA) and market access professionals are invited to apply for the European Market Access University Diploma (EMAUD). [...]
Register Today for Upcoming ISPOR Short Course On Health Technology Assessments
ISPOR will hold a virtual short course on health technology assessments (HTAs) on July 20th and 21st at 8:00 AM [...]
The Evidence Base Discusses RWE and HTA Spring Trends
Sreeram Ramagopalan of The Evidence Base discusses real world evidence (RWE) and health technology association (HTA) trends for April and [...]
JMCP Article Highlights Impact of Patient Experience on Value Framework
A recent article, published in the Journal of Managed Care and Specialty Pharmacy (JMCP), discusses how to incorporate the patient [...]
ISPOR Hosts Wednesday Webinar on International HTA Guidance
The Professional Society for Health Economics and Outcomes Research (ISPOR) will host a webinar on July 7th at 11:30 AM EDT [...]
